603658 安图生物
交易中 09-10 10:52:26
资讯
新帖
简况
太平洋：给予安图生物买入评级
证券之星 · 09-09 00:33
太平洋：给予安图生物买入评级
每周股票复盘：安图生物（603658）化学发光装机量创新高
证券之星 · 09-06
每周股票复盘：安图生物（603658）化学发光装机量创新高
安图生物新注册《去盖及在线消杀模块控制软件V1.0.0》项目的软件著作权
证券之星 · 09-04
安图生物新注册《去盖及在线消杀模块控制软件V1.0.0》项目的软件著作权
【机构调研记录】恒生前海基金调研安图生物、奕东电子
证券之星 · 09-02
【机构调研记录】恒生前海基金调研安图生物、奕东电子
安图生物最新公告：公司及二级子公司获得医疗器械注册证
证券之星 · 08-28
安图生物最新公告：公司及二级子公司获得医疗器械注册证
安图生物股价微跌0.71% 公司总市值达240.91亿元
金融界 · 08-26
安图生物股价微跌0.71% 公司总市值达240.91亿元
股市必读：安图生物(603658)股东户数3.42万户，较上期增加0.04%
证券之星 · 08-24
股市必读：安图生物(603658)股东户数3.42万户，较上期增加0.04%
安图生物最新公告：上半年度净利润5.71亿元 同比下降7.83%
证券之星 · 08-21
安图生物最新公告：上半年度净利润5.71亿元 同比下降7.83%
安图生物新注册《样本留样管理模块控制软件V1.0》项目的软件著作权
证券之星 · 08-17
安图生物新注册《样本留样管理模块控制软件V1.0》项目的软件著作权
安图生物新注册《高通量离心模块控制软件V1.0》项目的软件著作权
证券之星 · 08-12
安图生物新注册《高通量离心模块控制软件V1.0》项目的软件著作权
安图生物：其他流动资产主要为募集资金及现金管理产品
证券之星 · 08-12
安图生物：其他流动资产主要为募集资金及现金管理产品
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
安图生物涨5.06% 政策预期与资金博弈共振
智选洞察 · 08-07
安图生物涨5.06% 政策预期与资金博弈共振
每周股票复盘：安图生物（603658）获多项医疗器械注册证及增加募集资金专户
证券之星 · 08-02
每周股票复盘：安图生物（603658）获多项医疗器械注册证及增加募集资金专户
北美首展！安图生物携S900、Autof T 系列亮相 ADLM 2025
安图生物 · 07-31
北美首展！安图生物携S900、Autof T 系列亮相 ADLM 2025
安图生物中标乐山市医院试剂项目 券商看好助推业绩增长
自选股中标信息 · 07-30
安图生物中标乐山市医院试剂项目 券商看好助推业绩增长
安图生物最新公告：获得多项医疗器械注册证
证券之星 · 07-30
安图生物最新公告：获得多项医疗器械注册证
新冠检测概念盘中跳水，安图生物跌0.05%
市场透视 · 07-29
新冠检测概念盘中跳水，安图生物跌0.05%
安图生物与Mobidiag和解协议履行完毕
财中社 · 07-28
安图生物与Mobidiag和解协议履行完毕
安图生物：已赎回部分产品，实际收益204.54万元
公司公告 · 07-25
安图生物：已赎回部分产品，实际收益204.54万元
加载更多
公司概况
公司名称：
郑州安图生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2016-09-01
主营业务：
郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、检验辅助仪器。
发行价格：
14.58
{"stockData":{"symbol":"603658","market":"SH","secType":"STK","nameCN":"安图生物","latestPrice":41.37,"timestamp":1757472746000,"preClose":42.12,"halted":0,"volume":1669200,"delay":0,"changeRate":-0.0178,"floatShares":571000000,"shares":571000000,"eps":2.0055,"marketStatus":"交易中","change":-0.75,"latestTime":"09-10 10:52:26","open":42.11,"high":42.28,"low":41.31,"amount":69552900,"amplitude":0.023,"askPrice":41.39,"askSize":15,"bidPrice":41.37,"bidSize":8,"shortable":0,"etf":0,"ttmEps":2.0055,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1757475000000},"marketStatusCode":2,"adr":0,"adjPreClose":42.12,"symbolType":"stock","openAndCloseTimeList":[[1757467800000,1757475000000],[1757480400000,1757487600000]],"highLimit":46.33,"lowLimit":37.91,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":571424768,"isCdr":false,"pbRate":2.85,"roa":"--","peRate":20.628272,"roe":"6.51%","epsLYR":2.07,"committee":-0.038095,"marketValue":23640000000,"turnoverRate":0.0029,"status":1,"floatMarketCap":23640000000},"requestUrl":"/m/hq/s/603658","defaultTab":"news","newsList":[{"id":"2566656147","title":"太平洋：给予安图生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2566656147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566656147?lang=zh_cn&edition=full","pubTime":"2025-09-09 08:33","pubTimestamp":1757378022,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚,李啸岩近期对安图生物进行研究并发布了研究报告《安图生物：化学发光业务改善，盈利能力维持稳定》，给予安图生物买入评级。同时，公司对测序仪同样寄予厚望，预计近期获证。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有10家机构给出评级，买入评级9家，增持评级1家；过去90天内机构目标均价为51.38。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900007110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","601099"],"gpt_icon":0},{"id":"2565851003","title":"每周股票复盘：安图生物（603658）化学发光装机量创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2565851003","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565851003?lang=zh_cn&edition=full","pubTime":"2025-09-07 03:03","pubTimestamp":1757185393,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，安图生物报收于40.55元，较上周的40.57元下跌0.05%。本周，安图生物9月2日盘中最高价报41.66元。机构调研要点随着集采陆续落地执行，化学发光产品的价格出现了一定的下调，同时由于DRG政策的全面推行，使得整体市场的检测量有所减少；公司2024年的化学发光装机量创了新高，带来了一定的增量，销量上有一定增长。截至2025年上半年，终端医院的诊疗量变化不大，但检测量有所下降。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"gpt_icon":0},{"id":"2565754301","title":"安图生物新注册《去盖及在线消杀模块控制软件V1.0.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2565754301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565754301?lang=zh_cn&edition=full","pubTime":"2025-09-05 01:34","pubTimestamp":1757007257,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安图生物新注册了《去盖及在线消杀模块控制软件V1.0.0》项目的软件著作权。今年以来安图生物新注册软件著作权7个，较去年同期增加了600%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了2.5亿元，同比减24.87%。通过天眼查大数据分析，郑州安图生物工程股份有限公司共对外投资了19家企业，参与招投标项目1211次；财产线索方面有商标信息152条，专利信息599条，著作权信息6条；此外企业还拥有行政许可1559个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500001142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2564823259","title":"【机构调研记录】恒生前海基金调研安图生物、奕东电子","url":"https://stock-news.laohu8.com/highlight/detail?id=2564823259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564823259?lang=zh_cn&edition=full","pubTime":"2025-09-02 08:06","pubTimestamp":1756771587,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月1日披露的机构调研信息，恒生前海基金近期对2家上市公司进行了调研，相关名单如下：1）安图生物 调研纪要：随着集采落地和DRG政策推行，化学发光产品价格下调，检测量减少，但2024年装机量创新高，销量增长。2）奕东电子 调研纪要：2025年上半年，公司实现营业收入10.09亿元，同比增长27.77%，创历史同期新高，盈利能力持续提升，环比扭亏为盈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200006254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0214","BK0239","301123","BK0046","603658"],"gpt_icon":0},{"id":"2562084412","title":"安图生物最新公告：公司及二级子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2562084412","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562084412?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:15","pubTimestamp":1756372502,"startTime":"0","endTime":"0","summary":"安图生物公告称，安图生物及二级子公司郑州标源生物科技有限公司近日收到国家药品监督管理局颁发的医疗器械注册证，包括EB病毒早期抗原IgG抗体检测试剂盒、EB病毒早期抗原IgA抗体检测试剂盒、EB病毒衣壳抗原IgA抗体检测试剂盒、EB病毒核抗原IgA抗体检测试剂盒、肺炎链球菌/嗜肺军团菌/卡他莫拉菌核酸试剂盒以及异常凝血酶原/人表皮生长因子受体2/胃泌素释放肽前体/胃泌素17/S100蛋白质控品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800032173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0239","09997","BK1222","BK0046","BK1574","603658","BK1100","159883","09996"],"gpt_icon":0},{"id":"2562175160","title":"安图生物股价微跌0.71% 公司总市值达240.91亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562175160","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562175160?lang=zh_cn&edition=full","pubTime":"2025-08-27 02:45","pubTimestamp":1756233959,"startTime":"0","endTime":"0","summary":"安图生物8月26日股价报收42.16元，较前一交易日下跌0.30元，跌幅0.71%。当日成交量为31091手，成交金额1.31亿元，换手率为0.54%。安图生物属于医疗器械行业，公司主营业务为体外诊断试剂及仪器的研发、生产和销售。公司产品涵盖免疫诊断、微生物检测、分子诊断等多个领域。8月26日安图生物主力资金净流出1242.46万元，占流通市值的0.05%。近五个交易日主力资金累计净流出8156.87万元，占流通市值的0.34%。风险提示：股市有风险，投资需谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/27024552719635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","603658","BK0046"],"gpt_icon":0},{"id":"2562264290","title":"股市必读：安图生物(603658)股东户数3.42万户，较上期增加0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562264290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562264290?lang=zh_cn&edition=full","pubTime":"2025-08-25 04:27","pubTimestamp":1756067229,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，安图生物报收于41.94元，下跌0.02%，换手率0.81%，成交量4.64万手，成交额1.94亿元。交易信息汇总8月22日，安图生物的资金流向情况如下：主力资金净流出3298.78万元，占总成交额16.99%；游资资金净流入1326.53万元，占总成交额6.83%；散户资金净流入1972.26万元，占总成交额10.16%。股本股东变化近日安图生物披露，截至2025年6月30日公司股东户数为3.42万户，较3月31日增加15.0户，增幅为0.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500000987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2561687604","title":"安图生物最新公告：上半年度净利润5.71亿元 同比下降7.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561687604","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561687604?lang=zh_cn&edition=full","pubTime":"2025-08-21 17:19","pubTimestamp":1755767969,"startTime":"0","endTime":"0","summary":"安图生物(603658.SH)公告称，2025年上半年实现营业收入20.6亿元，同比下降6.65%；归属于上市公司股东的净利润5.71亿元，同比下降7.83%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100029410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"gpt_icon":0},{"id":"2560927056","title":"安图生物新注册《样本留样管理模块控制软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2560927056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560927056?lang=zh_cn&edition=full","pubTime":"2025-08-18 01:29","pubTimestamp":1755451750,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安图生物新注册了《样本留样管理模块控制软件V1.0》项目的软件著作权。今年以来安图生物新注册软件著作权5个，较去年同期增加了400%。结合公司2024年年报财务数据，2024年公司在研发方面投入了7.32亿元，同比增11.55%。通过天眼查大数据分析，郑州安图生物工程股份有限公司共对外投资了19家企业，参与招投标项目1190次；财产线索方面有商标信息152条，专利信息599条，著作权信息6条；此外企业还拥有行政许可1558个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800000432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"gpt_icon":0},{"id":"2559625906","title":"安图生物新注册《高通量离心模块控制软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2559625906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559625906?lang=zh_cn&edition=full","pubTime":"2025-08-13 01:33","pubTimestamp":1755019990,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安图生物新注册了《高通量离心模块控制软件V1.0》项目的软件著作权。今年以来安图生物新注册软件著作权4个，较去年同期增加了300%。结合公司2024年年报财务数据，2024年公司在研发方面投入了7.32亿元，同比增11.55%。通过天眼查大数据分析，郑州安图生物工程股份有限公司共对外投资了19家企业，参与招投标项目1175次；财产线索方面有商标信息152条，专利信息599条，著作权信息6条；此外企业还拥有行政许可1523个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081300001066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2558466326","title":"安图生物：其他流动资产主要为募集资金及现金管理产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2558466326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558466326?lang=zh_cn&edition=full","pubTime":"2025-08-12 18:21","pubTimestamp":1754994076,"startTime":"0","endTime":"0","summary":"证券之星消息，安图生物(603658)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！我看到2025年一季报中的其他流动资产有36亿多元，其主要包括哪些资产，能举例说明吗安图生物回复：尊敬的投资者您好，感谢您对公司的关注。公司2025年一季报中披露的其他流动资产主要为募集资金、自有资金的现金管理产品，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081200033306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持，行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高，支持性政策在产品注册、医保支付、行业标准等层面均有体现。1）在产品注册方面，国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策，脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688013","688108","159883","603014","688298","688366","603987","688026","688581","688580","688273","688029","688068","600055","688253","688314","688767","600645","688575","600587","603205","688075","688271","605369","688289","688410","688426","688468","688656","688351","603976","688114","688301","688085","688338","603880","688393","603309","688067","603222","688677","688613","688755","688617","688277","603387","603658","600807","688139","688198","688016","688606","688050","688212","688607","600529","560260","688317","688217","688151","688389","688193","688358","688576","688236","688161"],"gpt_icon":0},{"id":"2557584416","title":"安图生物涨5.06% 政策预期与资金博弈共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584416","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584416?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:37","pubTimestamp":1754530663,"startTime":"0","endTime":"0","summary":"安图生物股价大幅上涨，最新价42.15元/股，涨跌幅为5.06%。资金博弈与政策预期共振近期安图生物净流出主要源于资金面与政策预期的双向博弈。医疗服务价格调整预期引发调仓动作，叠加板块20日振幅达15.2%，加剧短期资金分歧。技术面上，39.1元的20日均线压制形成抛压，部分投资者在估值修复至动态市盈率20倍时选择获利了结，7月25日千万美元和解款到账后更强化了这一行为。当前21倍动态市盈率较板块均值折价约25%，3%股息率提供防御价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807093825a6d799ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807093825a6d799ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2556829114","title":"每周股票复盘：安图生物（603658）获多项医疗器械注册证及增加募集资金专户","url":"https://stock-news.laohu8.com/highlight/detail?id=2556829114","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556829114?lang=zh_cn&edition=full","pubTime":"2025-08-03 04:39","pubTimestamp":1754167148,"startTime":"0","endTime":"0","summary":"截至2025年8月1日收盘，安图生物报收于40.03元，较上周的40.3元下跌0.67%。本周关注点公司公告汇总：安图生物获得五项新产品医疗器械注册证，有效期均为5年。公司公告汇总安图生物关于获得医疗器械注册证的公告郑州安图生物工程股份有限公司近日收到河南省药品监督管理局颁发的医疗器械注册证，涉及五项产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080300000858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","09996","BK1574","BK0239","BK1583","BK1222","BK0046","159883","BK1100","603658"],"gpt_icon":0},{"id":"2555002303","title":"北美首展！安图生物携S900、Autof T 系列亮相 ADLM 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2555002303","media":"安图生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555002303?lang=zh_cn&edition=full","pubTime":"2025-07-31 15:28","pubTimestamp":1753946931,"startTime":"0","endTime":"0","summary":"安图生物有幸邀请到中华医学会检验医学分会的重要专家及多位美国知名学者来到展位，共同为首次在北美市场展出的两款明星产品：全自动化学发光免疫分析仪AutoLumo S900、全新一代微生物质谱检测系统Autof T系列揭幕。安图生物以“Lab in 0.5㎡”为核心设计理念，推出两款精巧设计、性能高效的产品。此次安图生物参展ADLM 2025，不仅展示了多领域的创新成果，也为持续拓展北美市场奠定了坚实的基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731154013a6cb191a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731154013a6cb191a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2555336041","title":"安图生物中标乐山市医院试剂项目 券商看好助推业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2555336041","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555336041?lang=zh_cn&edition=full","pubTime":"2025-07-30 18:39","pubTimestamp":1753871988,"startTime":"0","endTime":"0","summary":"2025年07月30日，据天眼查数据，乐山市市中区人民医院2025年检验科挂网试剂公开院内遴选结果公告显示，中标方为安图生物，招标方为乐山市市中区人民医院。近半年内，安图生物获得11家券商积极评价：太平洋证券和国联民生证券给予\"买入\"评级。安图生物主营业务涵盖试剂类，仪器类，其他，其他收入之和。截至发稿，安图生物股价报40.32元，上涨0.05%，成交额至1.59亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730183957a6c991d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730183957a6c991d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603658","BK0046"],"gpt_icon":0},{"id":"2555003019","title":"安图生物最新公告：获得多项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2555003019","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555003019?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:58","pubTimestamp":1753865910,"startTime":"0","endTime":"0","summary":"安图生物(603658.SH)公告称，公司近日收到河南省药品监督管理局颁发的医疗器械注册证，包括总IgE检测试剂盒、β2-微球蛋白检测试剂盒、特异性IgE抗体校准试剂盒、醛固酮检测试剂盒、粉尘螨过敏原特异性IgE抗体检测试剂盒和艾蒿过敏原特异性IgE抗体检测试剂盒等。这些注册证的取得丰富了公司产品菜单，提高产品竞争力，但对短期经营业绩影响较小。产品上市后销售情况取决于市场推广效果，对未来营业收入的影响尚无法预测。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000027146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","159883","09997","603658","BK1574","BK1222","BK0046","BK0239","BK1100","BK1583"],"gpt_icon":0},{"id":"2555120083","title":"新冠检测概念盘中跳水，安图生物跌0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555120083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555120083?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:57","pubTimestamp":1753754240,"startTime":"0","endTime":"0","summary":"07月29日，新冠检测概念盘中跳水，截至09点57分，新冠检测概念整体指数下跌1.04%，报956.020点。从个股上来看，该概念的成分股中，安图生物跌0.05%，跌幅居前。从资金上来看，截止发稿，新冠检测概念主力净流入为-4.82亿，其中海特生物受到资金热捧，主力净流入3578.86万；拉长时间线来看，该板块近20日主力资金净流入-61.34亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095720a6c6d56a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095720a6c6d56a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2554050773","title":"安图生物与Mobidiag和解协议履行完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2554050773","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554050773?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:29","pubTimestamp":1753694940,"startTime":"0","endTime":"0","summary":"7月28日，安图生物发布公告，关于《和解协议》履行完毕的情况。公司及其子公司与Mobidiag就《合资协议》和《许可、开发和分销协议》的履行产生分歧，向国际商会国际仲裁院申请仲裁。经过友好协商，双方达成和解并签订《和解协议》，公司申请撤案，仲裁庭终止了相关案件的诉讼程序。根据《和解协议》，Mobidiag同意在特定条件完成后，分期向公司支付总额为1000万美元的和解款项。2025年一季度，安图生物实现收入9.96亿元，归母净利润2.70亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281734299722f03b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281734299722f03b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2554762562","title":"安图生物：已赎回部分产品，实际收益204.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554762562","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554762562?lang=zh_cn&edition=full","pubTime":"2025-07-25 19:55","pubTimestamp":1753444519,"startTime":"0","endTime":"0","summary":"安图生物公告，公司使用不超过17亿元非公开发行股票闲置募集资金进行现金管理，本次涉及金额1.3亿元，用于购买大额存单等保本型产品。已赎回部分产品，包括6,000万元国债逆回购和1亿元大额存单，实际收益分别为7.73万元与196.81万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725195901a6c1b0e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725195901a6c1b0e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603658"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1757472753169,"stockEarnings":[{"period":"1week","weight":0.0276},{"period":"1month","weight":0.0286},{"period":"3month","weight":0.0867},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0944},{"period":"ytd","weight":-0.0029}],"compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0474},{"period":"3month","weight":0.119},{"period":"6month","weight":0.1336},{"period":"1year","weight":0.3913},{"period":"ytd","weight":0.1359}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"郑州安图生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34178人(较上一季度增加0.04%)","perCapita":"16719股","listingDate":"2016-09-01","address":"河南省郑州市管城回族区经济技术开发区经北一路87号","registeredCapital":"57142万元","survey":" 郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、检验辅助仪器。","listedPrice":14.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安图生物,603658,安图生物股票,安图生物股票老虎,安图生物股票老虎国际,安图生物行情,安图生物股票行情,安图生物股价,安图生物股市,安图生物股票价格,安图生物股票交易,安图生物股票购买,安图生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}